Andrew Roberts

Professor Andrew Roberts is head of Clinical Translation and a laboratory head in the Cancer and Hamatology division. He also works part-time as a clinical haematologist at the Royal Melbourne Hospital.A graduate of University of Queensland, he trained in clinical haematology for three years at Royal Brisbane Hospital and one year at Royal Melbourne Hospital before undertaking PhD studies with Don Metcalf 1993-1996. There he soon learned how little he really understood about haematology. After a post-doc in the Howard Hughes funded laboratory of David Williams, he returned to Melbourne to establish his own laboratory and translational research program. Current major research interests are the molecular regulation of haemopoiesis and the development of new treatments for lymphoma and leukaemia through translational and clinical research. He serves on the boards of the Cancer Council of Victoria, and the Australasian Leukaemia & Lymphoma Group (the national clinical trials group for blood cancer), as well as the Australian Governments’s Pharmaceutical Benefits Advisory Committee. He was President of Haematology Society of Australia and New Zealand 2005–07.

Professor Roberts' Cancer and Haematology Laboratory has close collaborative and physical ties with the Departments of Clinical Haematology and BMT, and Medical Oncology at the Royal Melbourne Hospital, where he conducts his clinical practice and clinical trial research. He also works closely in translational research with colleagues in the Chemical Biology division, particularly Professor David Huang. A team approach to facilitate internationally competitive research is fostered and each project is conducted in collaboration with other scientists and/or clinicians.